FierceBiotech

Mylan's Matrix Receives Tentative FDA Approval Under PEPFAR for First Generic, Heat-Stable Version of HIV Protease Inhibitor

PITTSBURGH, March 12 /PRNewswire-FirstCall/ -- Mylan Inc. (NASDAQ:MYL) today announced that Matrix Laboratories Limited, its India-based subsidiary in which it holds ...
FierceBiotech

Mylan's Matrix Receives Final FDA Approval for the Generic Version of the Antiretroviral Zerit(R) Capsules

PITTSBURGH, Dec. 30 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced that Matrix Laboratories Limited, its India-based subsidiary in which it holds ...
FiercePharma

Mylan's Matrix Receives Approval for Generic Version of Protonix® Delayed-release Tablets

PITTSBURGH, Jan. 24, 2011 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug ...